Ticker Scorecard - AGIO Basics Company: Agios Pharmaceuticals, Inc. IPO Date: July 24, 2013 Sector: Healthcare Industry: Biotech Market Cap: $1.95B Activated in VL: True Average Daily Range Avg Daily Range: $1.25 | 2.57% Avg Daily Range (30 D): $1.57 | 3.83% Avg Daily Range (90 D): $1.17 | 2.60% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): .88M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 5,472 Avg Inst. Trade: $2.33M Avg Inst. Trade (30 D): $2.86M Avg Inst. Trade (90 D): $2.62M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.15M Avg Closing Trade (30 D): $5.28M Avg Closing Trade (90 D): $4.69M Avg Closing Volume: 74.75K     News Jan 3, 2025 @ 12:00 PM Agios to Present at the 43rd Annual J.P. Morgan He... Source: N/A Dec 8, 2024 @ 5:40 PM Agios Presents Positive Results from Phase 3 ENERG... Source: N/A Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Oct 17, 2024 @ 11:00 AM Agios to Webcast Conference Call of Third Quarter ... Source: N/A Sep 5, 2024 @ 11:00 AM Agios to Present at the 2024 Cantor Global Healthc... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $16.65 $-1.69 $-1.45 Diluted EPS $16.22 $-1.69 $-1.45 Revenue $ 8.96M $ 8.62M $ 8.19M Gross Profit $ 8.18M $ 7.12M $ 7.56M Net Income / Loss $ 947.92M $ -96.12M $ -81.55M Operating Income / Loss $ -102.81M $ -105.82M $ -92.07M Cost of Revenue $ .78M $ 1.5M $ .63M Net Cash Flow $ 169.21M $ -34.25M $ 30.56M PE Ratio 2.13